313 related articles for article (PubMed ID: 28154320)
1. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
Nishiya N
Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
[TBL] [Abstract][Full Text] [Related]
2. A zebrafish chemical suppressor screening identifies small molecule inhibitors of the Wnt/β-catenin pathway.
Nishiya N; Oku Y; Kumagai Y; Sato Y; Yamaguchi E; Sasaki A; Shoji M; Ohnishi Y; Okamoto H; Uehara Y
Chem Biol; 2014 Apr; 21(4):530-540. PubMed ID: 24684907
[TBL] [Abstract][Full Text] [Related]
3. IMU1003, an atrarate derivative, inhibits Wnt/β-catenin signaling.
Yonezawa H; Sugawara A; Sakyo T; Uehara Y; Kawano T; Nishiya N
Biochem Biophys Res Commun; 2020 Nov; 532(3):440-445. PubMed ID: 32891433
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Wnt pathway in zebrafish as a screening method to identify novel therapeutic compounds.
Robertson JK; Danzmann K; Charles S; Blake K; Olivares A; Bamikole S; Olson M; Van Raay TJ
Exp Biol Med (Maywood); 2014 Feb; 239(2):169-76. PubMed ID: 24414478
[TBL] [Abstract][Full Text] [Related]
5. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
7. Polycyclic aromatic hydrocarbons and dibutyl phthalate disrupt dorsal-ventral axis determination via the Wnt/β-catenin signaling pathway in zebrafish embryos.
Fairbairn EA; Bonthius J; Cherr GN
Aquat Toxicol; 2012 Nov; 124-125():188-96. PubMed ID: 22975441
[TBL] [Abstract][Full Text] [Related]
8. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Wnt/β-catenin signaling pathway in human cancers.
Yao H; Ashihara E; Maekawa T
Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
[TBL] [Abstract][Full Text] [Related]
10. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between AhR and wnt/β-catenin signal pathways in the cardiac developmental toxicity of PM2.5 in zebrafish embryos.
Zhang H; Yao Y; Chen Y; Yue C; Chen J; Tong J; Jiang Y; Chen T
Toxicology; 2016 Apr; 355-356():31-8. PubMed ID: 27216425
[TBL] [Abstract][Full Text] [Related]
12. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT.
Bisson JA; Mills B; Paul Helt JC; Zwaka TP; Cohen ED
Dev Biol; 2015 Feb; 398(1):80-96. PubMed ID: 25482987
[TBL] [Abstract][Full Text] [Related]
14. Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening.
Yamaguchi K; Nagatoishi S; Tsumoto K; Furukawa Y
Cancer Sci; 2020 Mar; 111(3):783-794. PubMed ID: 31912579
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
Song P; Gao Z; Bao Y; Chen L; Huang Y; Liu Y; Dong Q; Wei X
J Hematol Oncol; 2024 Jun; 17(1):46. PubMed ID: 38886806
[TBL] [Abstract][Full Text] [Related]
16. The Wnt pathway: emerging anticancer strategies.
Gupta A; Verma A; Mishra AK; Wadhwa G; Sharma SK; Jain CK
Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):138-47. PubMed ID: 23432158
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C is required for normal Wnt/β-catenin signaling in the whisker follicle stem cell niche.
Hendaoui I; Tucker RP; Zingg D; Bichet S; Schittny J; Chiquet-Ehrismann R
Matrix Biol; 2014 Nov; 40():46-53. PubMed ID: 25196097
[TBL] [Abstract][Full Text] [Related]
18. Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells.
Li Y; Lu W; Saini SK; Moukha-Chafiq O; Pathak V; Ananthan S
Oncotarget; 2016 Mar; 7(10):11263-70. PubMed ID: 26820295
[TBL] [Abstract][Full Text] [Related]
19. The potential of targeting Wnt/β-catenin in colon cancer.
Sebio A; Kahn M; Lenz HJ
Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
[TBL] [Abstract][Full Text] [Related]
20. Berberine acts as a natural inhibitor of Wnt/β-catenin signaling--identification of more active 13-arylalkyl derivatives.
Albring KF; Weidemüller J; Mittag S; Weiske J; Friedrich K; Geroni MC; Lombardi P; Huber O
Biofactors; 2013; 39(6):652-62. PubMed ID: 23982892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
